News Quantified

NNVC – nanoviricides, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

InvestorNewsBreaks – NanoViricides (NYSE American: NNVC) to Initiate Phase II MPox Trial in DRC [TheStreet.com]

NanoViricides completes manufacturing of NV-387 oral drug ahead of Phase II mpox trial [Yahoo! Finance]

NanoViricides CEO discusses progress of broad-spectrum antiviral candidate NV-387 - ICYMI [Yahoo! Finance]

NanoViricides: Fiscal Q2 Earnings Snapshot [Yahoo! Finance]

NanoViricides seeks FDA orphan status for MPox drug [Yahoo! Finance]

Form D NANOVIRICIDES, INC.

Form 10-Q NANOVIRICIDES, INC. For: Dec 31

Top News Gainers

1/24 Form SC 13G/A NANOVIRICIDES, INC. Filed by: SABBY MANAGEMENT, LLC 85.9%

1/24 Form 424B1 NANOVIRICIDES, INC. 44.4%

4/21 NanoViricides to Present COVID-19 and Shingles Drug Development Update at the Planet MicroCap Showcase Virtual Investor Conference 2020 on April 22nd 38.7%

1/30 NanoViricides Confirms It Has Been Working On A Treatment For The Novel Wuhan Coronavirus 37.7%

1/23 World Health Organization Accelerating Diagnostics, Vaccines, Therapeutics For Novel Coronavirus 35.7%

10/16 Form PRE 14A NANOVIRICIDES, INC. For: Oct 15 19.5%

2/10 Nanoviricides President Dr. Diwan Was Interviewed by The Varney Show on Fox Business News 17.1%

1/10 Technological Advancements Expand Biopharmaceuticals' Production Capabilities 16.2%

8/20 Form 3 NANOVIRICIDES, INC. For: Jun 02 Filed by: Day Mark D. 13.2%

10/25 NanoViricides, Inc., Builds Promising Pipeline Targeting a Multi-Billion Dollar Market for Herpes and Shingles 12.9%

Top News Decliners

1/21 NanoViricides Prices $7.5 Million Underwritten Public Offering of Common Stock -58.5%

1/28 Form 8-K NANOVIRICIDES, INC. For: Jan 27 -50.3%

2/1 The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO [Yahoo! Finance News] -30.5%

9/30 Form S-1 NANOVIRICIDES, INC. -23.8%

9/26 Form 8-K NANOVIRICIDES, INC. For: Sep 22 -21.6%

1/6 NanoViricides Receives Cash Infusion of $2.25 Million -19.1%

3/24 Form S-3 NANOVIRICIDES, INC. -15.9%

11/29 Form S-1 NANOVIRICIDES, INC. -15.0%

6/3 NanoViricides has Received Favorable FDA Comments on Its Pre-IND Application for the Lead Drug Candidate -13.8%

12/3 NanoViricides Founder Dr. Diwan Provides $2,000,000 Loan Commitment to the Company -11.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day